Thermo Fisher Scientific Inc.

TMO · Healthcare · · USD

527.05 USD

+0.00 (0.45%)

● Updated 2026-07-11 21:11 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Long-term (Investment)

/ 100

Technical 75

Trend & RS 68

Momentum 44

Fundamental 82

Macro 75

Liquidity 48

Component	Score	Weight
Technical	75.0	10%
Trend & RS	67.5	10%
Momentum	44.3	5%
Fundamental	82.1	40%
Macro	74.8	15%
Liquidity	48.1	20%

Trade Setup

Entry	527.05
Stop Loss	497.99 (5.5%)
Target 1 (1:1)	556.11 (+5.5%)
Target 2 (2:1)	585.17 (+11.0%)

ATR(14)	14.53 (2.8%)
Risk per Share	29.06
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	48.3	-0.07
Momentum	44.3	-0.23
Quality	42.2	-0.31
Composite	44.9

Quality Scores

Piotroski F-Score 7 /9 — Strong

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 4.32 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Overvalued

Metric	Stock	Sector	vs Peers
P/E Ratio	29.0	22.0	+32% above
P/B Ratio	3.8	4.0	Inline
Dividend Yield	36.0%	1.5%	Above avg

Comparing against Healthcare median multiples.

Trading at a premium to sector peers — verify growth justifies premium.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

268.67

Market Price

527.05

Upside

-49.0%

Margin of Safety	-96.2%
Stage 1 PV (5yr FCF)	25,011,676,029
Terminal Value PV	74,831,639,393
Total Enterprise Value	99,843,315,422

Assumptions

Base FCF	5,404,862,587
Growth Rate (5yr)	6.2%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.8%

Recommended Size

45.8%

Full Kelly

22.9%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 70/100. Estimated win rate 61%, avg win 9.2%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

65.05

RSI(14)

13.1932

MACD

Relative Strength (RS) NEUTRAL

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	→ FLAT (-5.9% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (59d since high)
Sector Outperformance	+5.0% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

NEUTRAL: In line with the market — no strong outperformance or underperformance.

Technical Indicators

Indicator	Value	Signal
Rsi	65.05	NEUTRAL
Macd	13.1932	BULLISH
Ma Cross	477.25 / 526.58	DEATH CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.58x	NORMAL

Key Levels

Level	Price
52-Week High	643.99
Bollinger Upper	542.24
SMA(200)	526.58
SMA(50)	477.25
SMA(20)	495.09
Current Price	527.05
Bollinger Lower	447.93
52-Week Low	403.36
ATR(14)	14.53

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION E Confidence

50%

Acc: 1.0 | Dist: 1.0 | Markup: 0.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-07-06	Normal	0.87x	Normal bar — no special VSA pattern
2026-07-07	Normal	0.64x	Normal bar — no special VSA pattern
2026-07-08	Normal	0.94x	Normal bar — no special VSA pattern
2026-07-09	Normal	0.65x	Normal bar — no special VSA pattern
2026-07-10	Normal	0.58x	Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	514.09	Above Kijun
Kijun-sen (26)	495.36	Base line
Senkou A	504.73	Leading span A
Senkou B	483.96	Leading span B
Cloud	483.96 – 504.73	Bullish (Green)
Price vs Cloud	527.05	Above Cloud
Chikou Span	473.48	Bullish
Alignment Score	4/4	BULLISH